These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28545047)

  • 1. The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster.
    Marangi L; Mirinaviciute G; Flem E; Scalia Tomba G; Guzzetta G; Freiesleben de Blasio B; Manfredi P
    PLoS One; 2017; 12(5):e0176845. PubMed ID: 28545047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
    Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting.
    Sauboin C; Holl K; Bonanni P; Gershon AA; Benninghoff B; Carryn S; Burgess MA; Wutzler P
    BMC Infect Dis; 2019 Feb; 19(1):126. PubMed ID: 30727971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix.
    Ouwens MJ; Littlewood KJ; Sauboin C; Téhard B; Denis F; Boëlle PY; Alain S
    Clin Ther; 2015 Apr; 37(4):816-829.e10. PubMed ID: 25726457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.
    van Lier A; Lugnér A; Opstelten W; Jochemsen P; Wallinga J; Schellevis F; Sanders E; de Melker H; van Boven M
    EBioMedicine; 2015 Oct; 2(10):1494-9. PubMed ID: 26629544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of age-specific rates of reactivation and immune boosting of the varicella zoster virus.
    Marinelli I; van Lier A; de Melker H; Pugliese A; van Boven M
    Epidemics; 2017 Jun; 19():1-12. PubMed ID: 28007549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.
    Poletti P; Melegaro A; Ajelli M; Del Fava E; Guzzetta G; Faustini L; Scalia Tomba G; Lopalco P; Rizzo C; Merler S; Manfredi P
    PLoS One; 2013; 8(4):e60732. PubMed ID: 23613740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling the impact of varicella vaccination on varicella and zoster.
    Karhunen M; Leino T; Salo H; Davidkin I; Kilpi T; Auranen K
    Epidemiol Infect; 2010 Apr; 138(4):469-81. PubMed ID: 19796447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.
    van Hoek AJ; Melegaro A; Gay N; Bilcke J; Edmunds WJ
    Vaccine; 2012 Feb; 30(6):1225-34. PubMed ID: 22119592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination.
    Betta M; Laurino M; Pugliese A; Guzzetta G; Landi A; Manfredi P
    Proc Biol Sci; 2016 Mar; 283(1826):20160054. PubMed ID: 26984627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.
    van Hoek AJ; Melegaro A; Zagheni E; Edmunds WJ; Gay N
    Vaccine; 2011 Mar; 29(13):2411-20. PubMed ID: 21277405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varicella-zoster virus susceptibility and primary healthcare consultations in Norway.
    Rimseliene G; Vainio K; Gibory M; Salamanca BV; Flem E
    BMC Infect Dis; 2016 Jun; 16():254. PubMed ID: 27266273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
    Horn J; Karch A; Damm O; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Hengel H; Greiner W; Mikolajczyk RT
    Hum Vaccin Immunother; 2016 Jul; 12(7):1766-76. PubMed ID: 26835890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
    Goldman GS
    Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Epidemiology of Herpes Zoster After Varicella Immunization Under Different Biological Hypotheses: Perspectives From Mathematical Modeling.
    Guzzetta G; Poletti P; Merler S; Manfredi P
    Am J Epidemiol; 2016 Apr; 183(8):765-73. PubMed ID: 26994062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study.
    Thomas SL; Wheeler JG; Hall AJ
    Lancet; 2002 Aug; 360(9334):678-82. PubMed ID: 12241874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation.
    Ogunjimi B; Theeten H; Hens N; Beutels P
    J Med Virol; 2014 May; 86(5):812-9. PubMed ID: 24037981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013.
    Hobbelen PH; Stowe J; Amirthalingam G; Miller L; van Hoek AJ
    J Infect; 2016 Sep; 73(3):241-53. PubMed ID: 27283754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.
    Civen R; Chaves SS; Jumaan A; Wu H; Mascola L; Gargiullo P; Seward JF
    Pediatr Infect Dis J; 2009 Nov; 28(11):954-9. PubMed ID: 19536039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.